UROMIGOS
Live event will start inCOLLABORATING LABORATORIES – LABORATORIOS COLABORADORES
Live event will start inCOLLABORATING LABORATORIES – LABORATORIOS COLABORADORES
In a cohort of patients with a small renal mass (SRM) matched for age and health status, 5-yr outcomes for those managed with active surveillance…
CheckMate -901 is the first and only Phase 3 trial with an immunotherapy-based combination to demonstrate a survival benefit compared to standard-of-care cisplatin-based combinations in…
Striving to provide balanced, scientific content related to care of patients with GU malignancies. …
Our mission is to help patients with cancer live longer with better quality lives
Los expertos recuerdan que el 35% de los fármacos que se aprueban en Europa no llegan a España.